MedTrace Logo

Improving Adherence and Commitment to Treatment in Diabetic Patients

NCT02530840 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2018-02-01

No results posted yet for this study

Summary

In the IMPACT project, the investigators want to improve adherence and commitment to treatment.

Conditions

Interventions

BEHAVIORAL

medical team

Lowering HbA1c by behavioral changes in meetings with the medical team.

BEHAVIORAL

peers group

Lowering HbA1c by behavioral changes in meetings with the peers group.

BEHAVIORAL

SMS notification

Lowering HbA1c by behavioral changes in meetings with the SMS notification

Sponsors & Collaborators

  • Clalit Health Services

    lead OTHER

Principal Investigators

  • Margalit Goldfracht, prof. · Director of the Department of promoting quality of family medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2018-02-28
Completion
2018-03-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02530840 on ClinicalTrials.gov